BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34673602)

  • 21. Thanatophoric dysplasia: autopsy findings over a 25-year period.
    Vogt C; Blaas HG
    Pediatr Dev Pathol; 2013; 16(3):160-7. PubMed ID: 23323754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?
    Prontera P; Sensi A; Pilu G; Baldi M; Baffico M; Bonasoni R; Calzolari E
    Genet Couns; 2006; 17(4):407-12. PubMed ID: 17375526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal ultrasound and MRI findings of temporal and occipital lobe dysplasia in a twin with achondroplasia.
    Pugash D; Lehman AM; Langlois S
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):365-8. PubMed ID: 24616001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein-losing enteropathy with intestinal lymphangiectasia in skeletal dysplasia with Lys650Met mutation.
    Yang C; Dehner LP
    Am J Med Genet A; 2016 Nov; 170(11):2993-2997. PubMed ID: 27214123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia.
    Katsumata N; Kuno T; Miyazaki S; Mikami S; Nagashima-Miyokawa A; Nimura A; Horikawa R; Tanaka T
    Endocr J; 1998 Apr; 45 Suppl():S171-4. PubMed ID: 9790257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of thanatophoric dysplasia and lethal osteogenesis imperfecta type II in Northern Ireland - a complete population study.
    Donnelly DE; McConnell V; Paterson A; Morrison PJ
    Ulster Med J; 2010 Sep; 79(3):114-8. PubMed ID: 22375084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis.
    Hevner RF
    Acta Neuropathol; 2005 Sep; 110(3):208-21. PubMed ID: 16133544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of thanatophoric dysplasia type I (R248C) and hypochondroplasia (N540K) mutations in two patients with achondroplasia phenotype.
    Camera G; Baldi M; Strisciuglio G; Concolino D; Mastroiacovo P; Baffico M
    Am J Med Genet; 2001 Dec; 104(4):277-81. PubMed ID: 11754059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the co-occurrence of FGFR3 gene mutation in hypochondroplasia, medial temporal lobe dysgenesis, and focal epilepsy suggest a syndrome?
    Romeo A; Lodi M; Viri M; Parente E; Baldi M; Righini A; Milani D
    Pediatr Neurol; 2014 Apr; 50(4):427-30. PubMed ID: 24630288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell reprogramming for skeletal dysplasia drug repositioning.
    Karagiannis P; Tsumaki N
    Cell Cycle; 2014; 13(24):3791-2. PubMed ID: 25426543
    [No Abstract]   [Full Text] [Related]  

  • 31. Thanatophoric dysplasia type I with syndactyly.
    Brodie SG; Kitoh H; Lipson M; Sifry-Platt M; Wilcox WR
    Am J Med Genet; 1998 Nov; 80(3):260-2. PubMed ID: 9843049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone: statin therapy for skeletal dysplasia.
    Sargent J
    Nat Rev Endocrinol; 2014 Dec; 10(12):701. PubMed ID: 25265980
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid detection of K650E mutation in FGFR3 using uncultured amniocytes in a pregnancy affected with fetal cloverleaf skull, occipital pseudoencephalocele, ventriculomegaly, straight short femurs, and thanatophoric dysplasia type II.
    Chen CP; Chang TY; Lin MH; Chern SR; Su JW; Wang W
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):420-5. PubMed ID: 24075385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some chondrodysplasias with short limbs: molecular perspectives.
    Cohen MM
    Am J Med Genet; 2002 Oct; 112(3):304-13. PubMed ID: 12357475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional and four-dimensional HDlive-rendered images of thanatophoric dysplasia.
    Inubashiri E; Kuroki K; Maeda N; Kawai K; Akutagawa N; Sugawara M; Imai S; Minami K; Nomura Y
    J Med Ultrason (2001); 2015 Apr; 42(2):281-5. PubMed ID: 26576586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update.
    Lemyre E; Azouz EM; Teebi AS; Glanc P; Chen MF
    Can Assoc Radiol J; 1999 Jun; 50(3):185-97. PubMed ID: 10405653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autopsy case of thanatophoric dysplasia: observations on the serial sections of the brain.
    Yamaguchi K; Honma K
    Neuropathology; 2001 Sep; 21(3):222-8. PubMed ID: 11666020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1).
    Rousseau F; el Ghouzzi V; Delezoide AL; Legeai-Mallet L; Le Merrer M; Munnich A; Bonaventure J
    Hum Mol Genet; 1996 Apr; 5(4):509-12. PubMed ID: 8845844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thanatophoric dysplasia caused by double missense FGFR3 mutations.
    Pannier S; Martinovic J; Heuertz S; Delezoide AL; Munnich A; Schibler L; Serre V; Legeai-Mallet L
    Am J Med Genet A; 2009 Jun; 149A(6):1296-301. PubMed ID: 19449430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease models: Statins give bone growth a boost.
    Olsen BR
    Nature; 2014 Sep; 513(7519):494-5. PubMed ID: 25231860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.